APcK110
APcK110 is a novel, potent Kit inhibitor that suppresses proliferation in mastocytosis and AML cell lines by dose-dependently inhibiting Kit phosphorylation and downstream Stat3, Stat5, and Akt signaling. Its superior potency compared to imatinib and dasatinib in models like OCI/AML3 supports its research application in acute myeloid leukemia (AML) therapeutics.
Product Specifications
CAS Number
1001083-74-4
Field of Research
Signal Transduction
Smiles
FC1=CC=C (C=2C=3C (=NC (=CC3) C4=CC (OC) =CC (OC) =C4) NN2) C=C1
Molecular Formula
C20H16FN3O2
Molecular Weight
349.36
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog